We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
+15.61%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+535.77%
AUM
$4.74B
AUM Growth
+$743M
Cap. Flow
+$207M
Cap. Flow %
4.37%
Top 10 Hldgs %
17.46%
Holding
1,440
New
165
Increased
569
Reduced
526
Closed
100

Top Buys

Rank Stock Value
1
BIV icon
Vanguard Intermediate-Term Bond ETF
BIV
+$20.3M
2
VCSH icon
Vanguard Short-Term Corporate Bond ETF
VCSH
+$16.8M
3
JNK icon
State Street SPDR Bloomberg High Yield Bond ETF
JNK
+$16.2M
4
EMB icon
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
+$15.9M
5
CWB icon
State Street SPDR Bloomberg Convertible Securities ETF
CWB
+$15.5M

Top Sells

Rank Stock Value
1
SH icon
ProShares Short S&P500
SH
+$9.67M
2
LOW icon
Lowe's Companies
LOW
+$6.73M
3
ALB icon
Albemarle
ALB
+$5.55M
4
VEEV icon
Veeva Systems
VEEV
+$5.27M
5
CHWY icon
Chewy
CHWY
+$5.11M

Sector Composition

Rank Sector Weight
1 Technology 18.79%
2 Healthcare 11.15%
3 Financials 10.55%
4 Consumer Discretionary 9.84%
5 Industrials 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
M icon
1301
Macy's
M
$6.46B
$116K ﹤0.01%
+10,312
New +$88.2K
ARI
1302
Apollo Commercial Real Estate
ARI
$879M
$113K ﹤0.01%
10,125
-32,613
-76% -$334K
NAGE
1303
Niagen Bioscience
NAGE
$241M
$113K ﹤0.01%
+23,510
New +$115K
ICMB icon
1304
Investcorp Credit Management BDC
ICMB
$12.4M
$112K ﹤0.01%
23,516
-2,199
-9% -$8.66K
BCIC
1305
BCP Investment Corp
BCIC
$95M
$101K ﹤0.01%
+5,282
New +$79.6K
CBUS icon
1306
Cibus
CBUS
$150M
$94K ﹤0.01%
444
+160
+56% +$32.4K
MBIO icon
1307
Mustang Bio
MBIO
$4.64M
$94K ﹤0.01%
+33
New +$78.9K
JRO
1308
DELISTED
Nuveen Floating Rate Income Opportunty Fund
JRO
$90K ﹤0.01%
+10,445
New +$87K
SAN icon
1309
Banco Santander
SAN
$210B
$87K ﹤0.01%
28,545
-19,247
-40% -$48.7K
FEI
1310
DELISTED
FIRST TRUST MLP AND ENERGY INCOME FUND
FEI
$86K ﹤0.01%
14,839
+1,500
+11% +$8.37K
ENLC
1311
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$85K ﹤0.01%
22,895
-7,862
-26% -$25.8K
EVFM
1312
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$81K ﹤0.01%
2,235
-1,049
-32% -$37.9K
PSEC icon
1313
Prospect Capital
PSEC
$1.15B
$79K ﹤0.01%
14,625
+2,900
+25% +$15.3K
CRK icon
1314
Comstock Resources
CRK
$4.18B
$78K ﹤0.01%
+18,000
New +$89.1K
TXMD icon
1315
TherapeuticsMD
TXMD
$24.3M
$77K ﹤0.01%
1,285
+58
+5% +$3.96K
JMM icon
1316
Nuveen Multi-Market Income Fund
JMM
$55.2M
$74K ﹤0.01%
10,250
-400
-4% -$2.83K
TCRT icon
1317
Alaunos Therapeutics
TCRT
$4.81M
$73K ﹤0.01%
193
– –
GRCE
1318
Grace Therapeutics
GRCE
$44.6M
$73K ﹤0.01%
4,687
+629
+16% +$7.27K
IEAWW
1319
DELISTED
Infrastructure and Energy Alternatives, Inc. Warrant
IEAWW
$72K ﹤0.01%
+25,000
New +$32.7K
NGD
1320
DELISTED
New Gold Inc
NGD
$64K ﹤0.01%
28,946
-500
-2% -$1.02K
EGIO
1321
DELISTED
Edgio, Inc. Common Stock
EGIO
$63K ﹤0.01%
+393
New +$71.8K
MLSS icon
1322
Milestone Scientific
MLSS
$42M
$58K ﹤0.01%
27,500
– –
BTG icon
1323
B2Gold
BTG
$6.67B
$57K ﹤0.01%
10,200
– –
FPL
1324
DELISTED
FIRST TRUST NEW OPPORTUNITIES MLP & ENERGY FUND
FPL
$57K ﹤0.01%
13,341
-936
-7% -$3.85K
CMCM
1325
Cheetah Mobile
CMCM
$93.1M
$56K ﹤0.01%
6,204
– –
51 52
53
54 55

Similar funds

AC
Allstate Corporation Northbrook, Illinois $9.35B AUM 16.13% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.34B AUM 12.2% 1-Year Est. Return
WPL
WINDACRE PARTNERSHIP LLC Houston, Texas $9.34B AUM 17.41% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $9.32B AUM 33.19% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return

Oppenheimer & Co's Q4 2020 Portfolio in Review

As of Q4 2020, Oppenheimer & Co held 1,440 positions worth $4.74B, up 19% from $4B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Oppenheimer & Co deployed $207M of net new capital in Q4 2020, opening 165 new positions and adding to 569 existing holdings. Its largest new stake was State Street SPDR Bloomberg High Yield Bond ETF: 152,386 shares worth $16.6M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was ProShares Short S&P500, an estimated $9.67M trimmed.

  • Oppenheimer & Co's largest Q4 2020 buy was State Street SPDR Bloomberg High Yield Bond ETF: 152,386 shares worth $16.6M.
  • Oppenheimer & Co added most to Vanguard Intermediate-Term Bond ETF in Q4 2020, an estimated $20.3M increase.
  • Oppenheimer & Co's biggest Q4 2020 reduction was ProShares Short S&P500, cutting an estimated $9.67M.
  • Oppenheimer & Co fully exited PagerDuty in Q4 2020, selling an estimated $2.96M.
  • Oppenheimer & Co's ten largest holdings make up 17% of its $4.74B portfolio in Q4 2020.
  • Oppenheimer & Co opened 165 new positions and closed 100 in Q4 2020.
  • Oppenheimer & Co's portfolio value rose 19% quarter-over-quarter to $4.74B.

Based on Oppenheimer & Co's 13F filing for Q4 2020, filed 11 Feb 2021.